Meridian Bioscience (VIVO) Aandeel Koers
Meridian Bioscience Koers
In de afgelopen 19 jaar liet Meridian Bioscience de omzet jaarlijks met 8,9% groeien tot 333,02 Miljoen USD. De winst per aandeel is de afgelopen 19 jaar met 8,4% per jaar gegroeid. Bij Meridian Bioscience is de nettowinstmarge met 12,7% ten opzichte van 11,1% enkele jaren geleden gestegen. Op de huidige koers komt het dividendrendement uit op ongeveer 5,51%. De uitkeringsratio ligt rond 22% van de winst.
Meridian Bioscience aandeelkoers
Deze data ophalen via de Eulerpool API
100.000 requests/maand gratis · geen creditcard
Meridian Bioscience bedrijfsmodel & aandelenanalyse
Veelgestelde vragen over Meridian Bioscience
The business model of Meridian Bioscience Inc revolves around manufacturing and distributing diagnostic products for the healthcare industry. With a focus on infectious disease testing, the company provides a range of products including molecular and immunoassay tests, as well as reagents and related equipment. Meridian Bioscience Inc aims to develop innovative solutions for quick and accurate diagnosis, helping healthcare professionals worldwide make informed decisions. Through its expertise and continual investment in research and development, the company strives to improve patient outcomes and contribute to the overall public health. Meridian Bioscience Inc's commitment to quality and customer satisfaction is evident in their comprehensive portfolio of diagnostic solutions.
Meridian Bioscience Inc is primarily active in the healthcare and life sciences industries.
The main competitors of Meridian Bioscience Inc in the market are companies like Thermo Fisher Scientific, BD (Becton, Dickinson and Company), Quidel Corporation, and Bio-Rad Laboratories. These companies operate in the healthcare and diagnostics industry, offering similar products and services. Meridian Bioscience Inc competes based on factors such as product quality, technological advancements, pricing strategy, and customer satisfaction. While Thermo Fisher Scientific is a well-established player in the market, Meridian Bioscience Inc continues to carve its niche through innovative solutions and a strong customer-centric approach.
Meridian Bioscience Inc is a leading life science company that develops and markets a broad range of innovative diagnostic products. Founded in 1976, the company has a rich history and a strong background in developing and commercializing diagnostic tests for various infectious diseases. Meridian Bioscience Inc has evolved over the years and has expanded its product portfolio to cater to the needs of laboratories, hospitals, and other healthcare providers worldwide. With a focus on quality, accuracy, and reliability, the company has garnered a reputation for delivering efficient and effective diagnostic solutions. Meridian Bioscience Inc remains committed to advancing healthcare and improving patient outcomes through its cutting-edge diagnostic technologies and dedication to innovation.
Meridian Bioscience Inc has achieved several significant milestones throughout its history. One notable accomplishment is the company's development and commercialization of innovative diagnostic test kits for various diseases and healthcare conditions. Furthermore, Meridian Bioscience Inc has consistently expanded its product portfolio, introducing novel technologies to improve healthcare outcomes. The company's dedication to research and development has led to the successful launch of multiple FDA-cleared and CE-marked diagnostic tests. Meridian Bioscience Inc's commitment to quality has enabled it to establish a strong presence in the global diagnostics market.
Meridian Bioscience Inc is primarily present in the United States.
Meridian Bioscience Inc represents a strong set of values and corporate philosophy. The company is committed to quality and innovation in the field of biotechnology. They strive to provide accurate and reliable diagnostic solutions to improve patient care. Meridian Bioscience Inc also prioritizes integrity and ethical conduct in all aspects of their business operations. With a focus on customer satisfaction, they aim to exceed expectations and deliver exceptional products and services. As an industry leader, Meridian Bioscience Inc continues to drive advancements in the healthcare sector through their dedication to excellence and integrity.
7 analisten beoordelen het aandeel Meridian Bioscience momenteel: 6 adviseren kopen, 1 houden en 0 verkopen.
Omgezet tegen de huidige wisselkoers noteert het aandeel Meridian Bioscience op 2,02 EUR (2,27 USD).
Het aandeel Meridian Bioscience (VIVO) is genoteerd aan 4 beurzen, waaronder: NASDAQ (VIVO), London (0K0K.L), Frankfurt (MR4.F), München (MR4.MU).
Meridian Bioscience Inc is a global company specializing in the development, manufacture, and distribution of diagnostic and testing systems for the rapid and accurate identification of infectious diseases. The company was founded in 1976 and is headquartered in Cincinnati, Ohio. Meridian Bioscience operates several business segments, including diagnostics, OEM, and life science. In the diagnostics segment, the company offers a variety of products for the identification of infectious diseases, including tests for respiratory infections, gastroenteritis, STDs, and Zika virus. Meridian Bioscience's diagnostic products are used in clinical laboratories, hospitals, medical practices, and research laboratories worldwide. The OEM segment of Meridian Bioscience offers customized diagnostic products tailored to the specific requirements of OEM customers. This includes both raw materials and finished products that can be integrated into customers' diagnostic products. The OEM segment of Meridian Bioscience works closely with OEM customers to provide customized, cost-effective, and high-quality products. In the life science segment, Meridian Bioscience offers a wide range of products, including enzymes, antibodies, proteins, buffering solutions, and labeling reagents. These products are used in research and development, diagnostics, and industry. Meridian Bioscience has experienced strong growth in recent years, driven by the introduction of new products, expansion into new markets, and the acquisition of other companies. An example of this is the acquisition of the Bioline Group in 2018, a leading provider of molecular biology products used in research and diagnostics. Meridian Bioscience is committed to developing and manufacturing high-quality products that deliver fast and accurate results. The company works closely with customers and partners to develop innovative products that meet the needs of the healthcare industry. With its wide range of products and commitment to innovation and quality, Meridian Bioscience will continue to play an important role in the diagnostics industry.
De omzet kan momenteel niet worden berekend voor Meridian Bioscience.
De winst kan momenteel niet worden berekend voor Meridian Bioscience.
De P/E-ratio kan momenteel niet worden berekend voor Meridian Bioscience.
De P/S-ratio kan momenteel niet worden berekend voor Meridian Bioscience.
De Eulerpool Kwaliteitsscore voor Meridian Bioscience is 6/10.
De ISIN van Meridian Bioscience is US5895841014. De ISIN (International Securities Identification Number) is een wereldwijd unieke identificatie voor wertpapieren.
De WKN van Meridian Bioscience is 871583. De WKN (Wertpapierkennnummer) is een zescijferig Duits identificatienummer voor wertpapieren.
Het tickersymbool van Meridian Bioscience is VIVO. Onder dit beurstickersymbool wordt het Meridian Bioscience-aandeel op de beurs verhandeld.
Meridian Bioscience aandeel
Meridian Bioscience Peer Group
Meridian Bioscience Ticker
Meridian Bioscience FIGI
Alle fundamentals en diepgaande analyse van Meridian Bioscience
Onze aandelenanalyse van het Meridian Bioscience-aandeel omvat belangrijke financiële kerncijfers zoals de omzet, de winst, de P/E-ratio, de P/S-ratio, de EBIT, evenals informatie over het dividend. Daarnaast bekijken we aspecten zoals aandelen, marktkapitalisatie, schulden, eigen vermogen en verplichtingen van Meridian Bioscience. Als u meer gedetailleerde informatie zoekt over deze onderwerpen, bieden we op onze subpagina's uitgebreide analyses: